There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cigna (CI – Research Report) and Johnson & Johnson (JNJ – Research Report) with bullish sentiments. Cigna (CI) Stephens analyst Scott Fidel maintained a Buy rating on Cigna today and set a price target of $290.00. The company's shares closed last Tuesday at $261.03, close to its 52-week high of $272.81. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cigna-ci-and-johnson-johnson-jnj?utm_source=advfn.com&utm_medium=referral